These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 3519439)

  • 1. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
    Leu RW; Rummage JA; Rahimi MB; Herriott MJ
    Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.
    Leu RW; Rummage JA; Horn MJ
    Immunobiology; 1989 Feb; 178(4-5):340-50. PubMed ID: 2469639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
    Boraschi D; Soldateschi D; Tagliabue A
    Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability.
    Leu RW; Zhou AQ; Rummage JA; Kennedy MJ; Shannon BJ
    J Immunol; 1989 Nov; 143(10):3250-7. PubMed ID: 2809201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.
    Leu RW; Zhou AQ; Kennedy MJ; Shannon BJ
    J Immunol; 1991 Feb; 146(4):1233-9. PubMed ID: 1991965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors.
    Stein M; Gordon S
    Eur J Immunol; 1991 Feb; 21(2):431-7. PubMed ID: 1999225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
    Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
    J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibitors of C1q biosynthesis on macrophage Fc receptor subclass-mediated antibody-dependent cellular cytotoxicity and phagocytosis.
    Mocharla R; Mocharla H; Leu RW
    Cell Immunol; 1987 Mar; 105(1):127-35. PubMed ID: 3028650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of macrophage immune and nonimmune receptor-mediated phagocytosis by a low molecular weight soluble factor from resident thymocytes.
    Coleman DL; Culver KE; Ryan JL
    J Immunol; 1984 Dec; 133(6):3121-7. PubMed ID: 6386982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors.
    Zahedi K; Tebo JM; Siripont J; Klimo GF; Mortensen RF
    J Immunol; 1989 Apr; 142(7):2384-92. PubMed ID: 2926136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
    Ohyama K
    Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
    Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
    J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.